Home › Funds › EcoR1 Capital, LLC › RLAY
EcoR1 Capital, LLC position in RLAY
RELAY THERAPEUTICS INC COM · Health Care
EcoR1 Capital, LLC reported holding 697,948 shares of RLAY (RELAY THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$13.1M, representing 0.67% of its reported portfolio and ranking #18 among its reported holdings. EcoR1 Capital, LLC has disclosed RLAY holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's RLAY position evolved
EcoR1 Capital, LLC first disclosed a stake in RLAY in Q3 2023 at 4,163,824 shares (US$35.0M). Across 6 filings, EcoR1 Capital, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 697,948 shares valued at US$13.1M — a reduction of -1,206,814 shares quarter over quarter.. Notable position changes include a 74% trim in Q4 2024 (shares fell 36% over the following quarter), a 63% trim in Q2 2026 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.16M | $35.02M | New |
| Q3 2024 | 2.50M | $17.70M | New |
| Q4 2024 | 641.43K | $2.64M | Reduce |
| Q1 2025 | 641.43K | $1.68M | Hold |
| Q1 2026 | 1.90M | $18.95M | New |
| Q2 2026 | 697.95K | $13.06M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLAY and 13F data
RLAY (RELAY THERAPEUTICS INC COM) is a Health Care company. 64 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLAY
- SB INVESTMENT ADVISERS (UK) LTD 27.90M sh · $522.10M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- PERCEPTIVE ADVISORS LLC 14.11M sh · $263.93M · Q2 2026
- Commodore Capital LP 12.00M sh · $224.52M · Q2 2026
- Nextech Invest Ltd. 6.78M sh · $126.79M · Q2 2026
- Bellevue Group AG 6.19M sh · $115.74M · Q2 2026
- TCG Crossover Management, LLC 4.27M sh · $79.95M · Q2 2026
- Siren, L.L.C. 3.65M sh · $68.29M · Q2 2026
- Kynam Capital Management, LP 3.30M sh · $61.74M · Q2 2026
- Spruce Street Capital LP 2.98M sh · $55.83M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M sh · $52.89M · Q2 2026
- MPM BioImpact LLC 2.42M sh · $45.20M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held RLAY?
EcoR1 Capital, LLC has disclosed RLAY holdings in 6 of the last 12 reported quarters, going back to Q3 2023.
What is EcoR1 Capital, LLC's current position in RLAY?
As of Q2 2026, EcoR1 Capital, LLC holds 697.95K shares of RLAY (RELAY THERAPEUTICS INC COM), valued at $13.06M, representing 0.67% of its reported portfolio and ranking #18.
Has EcoR1 Capital, LLC been buying or selling RLAY?
In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC reduced its position in RLAY.
Which other funds hold RLAY?
Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.